Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shyam Daya

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Microbiology Reviews|October 16, 2008
Gene therapy using adeno-associated virus vectorsShyam Daya, Kenneth I Berns
Journal of Virology|September 18, 2009
Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathwayShyam Daya, Nenita Cortez, Kenneth I Berns
Case Reports in Oncological Medicine|November 4, 2016
Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the LiteratureWilfred Delacruz, Robert Setlik, Arash Hassantoufighi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Microbiology Reviews|October 16, 2008
Gene therapy using adeno-associated virus vectorsShyam Daya, Kenneth I Berns
Journal of Virology|September 18, 2009
Adeno-associated virus site-specific integration is mediated by proteins of the nonhomologous end-joining pathwayShyam Daya, Nenita Cortez, Kenneth I Berns
Case Reports in Oncological Medicine|November 4, 2016
Novel Brentuximab Vedotin Combination Therapies Show Promising Activity in Highly Refractory CD30+ Non-Hodgkin Lymphoma: A Case Series and Review of the LiteratureWilfred Delacruz, Robert Setlik, Arash Hassantoufighi, et al.
Pageof 1